Medicare Enrolled
Dr. Andrea Amico
Hematology & Oncology · Maywood, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Amico from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Amico?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Amico
Dr. Andrea Amico is a hematology & oncology specialist in Maywood, IL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Amico performed 472 Medicare services across 385 unique beneficiaries.
Between the years covered by Open Payments, Dr. Amico received a total of $4,553 from 40 pharmaceutical and/or device companies across 129 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Amico is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ 472 Medicare services
$4,553 industry payments
Medicare Practice Summary
Medicare Utilization ↗472
Medicare services
Bottom 27% in IL for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
385
Unique beneficiaries
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~28 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
99 | $86 | $410 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
91 | $65 | $142 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
45 | $107 | $240 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
42 | $99 | $218 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
34 | $131 | $486 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
29 | $142 | $367 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
27 | $42 | $88 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
26 | $44 | $277 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
24 | $103 | $360 |
| New patient office visit, complex (60-74 min) | 24 | $146 | $447 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
16 | $71 | $190 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
15 | $31 | $132 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,553
Total received (2018-2024)
Avg $1,138/year across 4 years
Top 44% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
129
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,642 (58.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,887 (41.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$23 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,710
2023
$810
2019
$1,910
2018
$123
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$162
PFIZER INC.
$159
AstraZeneca Pharmaceuticals LP
$123
Celgene Corporation
$109
Daiichi Sankyo Inc.
$90
E.R. Squibb & Sons, L.L.C.
$85
Eisai Inc.
$79
Tactile Systems Technology Inc
$76
Exelixis Inc.
$75
TerSera Therapeutics LLC
$64
Gilead Sciences, Inc.
$64
Janssen Pharmaceuticals, Inc
$57
Janssen Biotech, Inc.
$57
Genentech USA, Inc.
$43
Mirati Therapeutics, Inc.
$43
PUMA BIOTECHNOLOGY, INC.
$39
BeiGene USA, Inc.
$36
ABBVIE INC.
$33
GlaxoSmithKline, LLC.
$33
Tempus AI, Inc
$28
Ipsen Biopharmaceuticals, Inc
$27
Rigel Pharmaceuticals, Inc.
$27
EMD Serono, Inc.
$26
Takeda Pharmaceuticals U.S.A., Inc.
$23
Alexion Pharmaceuticals, Inc.
$21
Lilly USA, LLC
$21
Merck Sharp & Dohme LLC
$21
Bayer Healthcare Pharmaceuticals Inc.
$21
SOBI, INC
$19
GENZYME CORPORATION
$18
ARRAY BIOPHARMA INC
$18
Incyte Corporation
$13
Top 3 companies account for 26.0% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$1,887
Novartis Pharmaceuticals Corporation
$308
PFIZER INC.
$268
Genentech USA, Inc.
$214
Celgene Corporation
$167
AstraZeneca Pharmaceuticals LP
$145
Daiichi Sankyo Inc.
$131
E.R. Squibb & Sons, L.L.C.
$114
Gilead Sciences, Inc.
$108
Janssen Biotech, Inc.
$99
Eisai Inc.
$79
Tactile Systems Technology Inc
$76
Exelixis Inc.
$75
TerSera Therapeutics LLC
$64
Merck Sharp & Dohme LLC
$59
Janssen Pharmaceuticals, Inc
$57
Takeda Pharmaceuticals U.S.A., Inc.
$56
GlaxoSmithKline, LLC.
$49
Mirati Therapeutics, Inc.
$43
Seagen Inc.
$42
Astellas Pharma US Inc
$41
PUMA BIOTECHNOLOGY, INC.
$39
GENZYME CORPORATION
$37
BeiGene USA, Inc.
$36
ABBVIE INC.
$33
Tempus AI, Inc
$28
Ipsen Biopharmaceuticals, Inc
$27
Rigel Pharmaceuticals, Inc.
$27
EMD Serono, Inc.
$26
Incyte Corporation
$26
Alexion Pharmaceuticals, Inc.
$21
Lilly USA, LLC
$21
Bayer Healthcare Pharmaceuticals Inc.
$21
Deciphera Pharmaceuticals Inc.
$20
Karyopharm Therapeutics Inc.
$19
SOBI, INC
$19
Emmaus Medical, Inc.
$19
ARRAY BIOPHARMA INC
$18
Amgen Inc.
$17
ImmunoGen, Inc.
$16
Top 3 companies account for 54.1% of all-time payments
Associated products mentioned in payments ›
Alecensa · Avastin · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · DARZALEX · ELAHERE · ELIQUIS · ENHERTU · ENJAYMO · Elahere · Endari · Enhertu · Flexitouch Plus · IBRANCE · IMFINZI · INLYTA · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · LORBRENA · LYNPARZA · Lenvima · NINLARO · Nplate · Nubeqa · OPDIVO · OXBRYTA · Onivyde · PADCEV · PLUVICTO · PROMACTA · Padcev · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Rezlidhia · SCEMBLIX · SIMPONI ARIA · TALZENNA · TECVAYLI · TUKYSA · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · Vanflyta · Venclexta · XARELTO · XPOVIO · Xermelo · Xtandi · ZEJULA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (58%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
351
Per 100K population
6.8
County median income
$81,797
Nearest hospital
LOYOLA UNIVERSITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Amico is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Amico experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Amico performed 99 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Amico receive payments from pharmaceutical companies?
Yes. Dr. Amico received a total of $4,553 from 40 companies across 129 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Amico's costs compare to other hematology & oncology specialists in Maywood?
Dr. Amico's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Amico) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Maywood
Browse hematology & oncology specialists in Maywood ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in IL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in IL
Which IL hematology & oncology specialists receive the most from drug and device companies.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology